Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
NIKKEI 225
38,405.66
+470.90
(+1.24%)
HANG SENG
17,763.03
+16.12
(+0.09%)
CRUDE OIL
81.88
-0.75
(-0.91%)
GOLD FUTURES
2,305.80
-51.90
(-2.20%)
DOW
37,970.22
-415.87
(-1.08%)
Bitcoin GBP
50,119.69
-539.11
(-1.06%)
Stocks
Trending tickers: Amazon, Tesla, Samsung, Mercedes-Benz, Whitbread
The latest investor updates on stocks that are trending on Tuesday
Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.15
+0.12
(+1.04%)
As of 02:44PM EDT. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,189
1,189
0
0
0
Cost of revenue
10,755
10,755
0
0
-
Gross profit
-9,566
-9,566
0
0
-
Operating expenses
Research development
344,077
344,077
294,781
259,039
201,727
Selling general and administrative
106,916
106,916
104,097
83,664
60,210
Total operating expenses
450,993
450,993
398,878
342,703
261,937
Operating income or loss
-460,559
-460,559
-398,878
-342,703
-261,937
Income before tax
-447,516
-447,516
-395,893
-342,252
-259,581
Income tax expense
-3,479
-3,479
0
0
-
Income from continuing operations
-444,037
-444,037
-395,893
-342,252
-259,581
Net income
-444,037
-444,037
-395,893
-342,252
-259,581
Net income available to common shareholders
-444,037
-444,037
-395,893
-342,252
-259,581
Basic EPS
-2.08
-1.89
-2.49
-2.23
-1.88
Diluted EPS
-2.08
-1.89
-2.49
-2.23
-1.88
Basic average shares
212,292
235,131
159,259
153,406
138,301
Diluted average shares
212,292
235,131
159,259
153,406
138,301
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.